AARDVARK BIOTECH LIMITED

Company Registration Number:
03502208 (England and Wales)

Unaudited abridged accounts for the year ended 31 January 2018

(Dormant)

Period of accounts

Start date: 01 February 2017

End date: 31 January 2018

AARDVARK BIOTECH LIMITED

Contents of the Financial Statements

for the Period Ended 31 January 2018

Company Information - 3
Balance sheet - 4
Additional notes - 6

AARDVARK BIOTECH LIMITED

Company Information

for the Period Ended 31 January 2018




Director: S N DAVEY
Registered office: 11
Drysdale Avenue
London
E4 7NL
Company Registration Number: 03502208 (England and Wales)

AARDVARK BIOTECH LIMITED

Balance sheet

As at 31 January 2018


Notes

2018
£

2017
£
Fixed assets
Current assets
Cash at bank and in hand: 154 154
Total current assets: 154 154
Net current assets (liabilities): 154 154
Total assets less current liabilities: 154 154
Total net assets (liabilities): 154 154

The notes form part of these financial statements

AARDVARK BIOTECH LIMITED

Balance sheet continued

As at 31 January 2018


Notes

2018
£

2017
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 54 54
Shareholders funds: 154 154

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 31 January 2018 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

This report was approved by the board of directors on 20 February 2018
And Signed On Behalf Of The Board By:

Name: S N DAVEY
Status: Director

The notes form part of these financial statements

AARDVARK BIOTECH LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2018

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102